The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.
Research output: Contribution to journal › Article › peer-review
Standard Standard
The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. / F, Pellicano; MT, Scott; GV, Helgason et al.
In: Stem Cells, Vol. 32, No. 9, 18.08.2014, p. 2324-2337.
In: Stem Cells, Vol. 32, No. 9, 18.08.2014, p. 2324-2337.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
F, P, MT, S, GV, H, LE, H, EK, A, M, A-OD, M, C, A, P, BJ, H, AD, W & TL, H 2014, 'The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.', Stem Cells, vol. 32, no. 9, pp. 2324-2337. https://doi.org/10.1002/stem.1748
APA
F, P., MT, S., GV, H., LE, H., EK, A., M, A.-OD., M, C., A, P., BJ, H., AD, W., & TL, H. (2014). The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. Stem Cells, 32(9), 2324-2337. https://doi.org/10.1002/stem.1748
CBE
F P, MT S, GV H, LE H, EK A, M A-OD, M C, A P, BJ H, AD W, et al. 2014. The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. Stem Cells. 32(9):2324-2337. https://doi.org/10.1002/stem.1748
MLA
F, Pellicano et al. "The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.". Stem Cells. 2014, 32(9). 2324-2337. https://doi.org/10.1002/stem.1748
VancouverVancouver
F P, MT S, GV H, LE H, EK A, M AOD et al. The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. Stem Cells. 2014 Aug 18;32(9):2324-2337. doi: 10.1002/stem.1748
Author
RIS
TY - JOUR
T1 - The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.
AU - F, Pellicano
AU - MT, Scott
AU - GV, Helgason
AU - LE, Hopcroft
AU - EK, Allan
AU - M, Aspinall-O'Dea
AU - M, Copland
AU - A, Pierce
AU - BJ, Huntly
AU - AD, Whetton
AU - TL, Holyoake
PY - 2014/8/18
Y1 - 2014/8/18
U2 - 10.1002/stem.1748
DO - 10.1002/stem.1748
M3 - Article
VL - 32
SP - 2324
EP - 2337
JO - Stem Cells
JF - Stem Cells
SN - 1549-4918
IS - 9
ER -